SNCA and Parkinson disease: In the study by Park et al. [76], mice treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a widely used neurotoxin to induce PD-like symptoms in animal models, and mice expressing human α-synuclein exhibited a significant reduction in motor performance.